Atlas Trials

Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin

Clinical trial NCT00230854 · COMPLETED

Trial details

NCT number
NCT00230854
Sponsor
OPKO Health, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Hepatitis CHepatitis, Viral, Human
Start date
2005-08-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.